These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27500307)

  • 1. Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice.
    Waseem M; Khan I; Iqbal H; Eijaz S; Usman S; Ahmed N; Alam G; Salim A
    Cell Reprogram; 2016 Oct; 18(5):344-355. PubMed ID: 27500307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus.
    Li L; Li F; Gao F; Yang Y; Liu Y; Guo P; Li Y
    Cell Tissue Res; 2016 May; 364(2):345-55. PubMed ID: 26650464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mouse pancreatic islet function by co‑culture with hypoxia pre‑treated mesenchymal stromal cells.
    Xiang C; Xie QP
    Mol Med Rep; 2018 Sep; 18(3):2589-2598. PubMed ID: 30015882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinitrophenol modulates gene expression levels of angiogenic, cell survival and cardiomyogenic factors in bone marrow derived mesenchymal stem cells.
    Ali A; Akhter MA; Haneef K; Khan I; Naeem N; Habib R; Kabir N; Salim A
    Gene; 2015 Jan; 555(2):448-57. PubMed ID: 25445267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lawsone-preconditioned mesenchymal stem cells on the regeneration of pancreatic β cells in Type 1 diabetic rats.
    Masnoon J; Ishaque A; Khan I; Salim A; Kabir N
    Cell Biochem Funct; 2023 Oct; 41(7):833-844. PubMed ID: 37814478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Stem Cells Ameliorate the Pancreatic Damage Induced by Streptozotocin in Rats?
    El Barky AR; Ezz AAH; Alm-Eldeen AA; Hussein SA; Hafez YA; Mohamed TM
    Can J Diabetes; 2018 Feb; 42(1):61-70. PubMed ID: 28642056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic stress and IL-7 gene overexpression enhance the fusion potential of rat bone marrow mesenchymal stem cells with bovine renal epithelial cells.
    Habib R; Haneef K; Naeem N; Khan I; Jamall S; Atta-Ur-Rahman ; Salim A
    Mol Cell Biochem; 2015 May; 403(1-2):125-37. PubMed ID: 25666089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
    Amer MG; Embaby AS; Karam RA; Amer MG
    Gene; 2018 May; 654():87-94. PubMed ID: 29452233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypoxia on the proliferation of porcine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells in 2- and 3-dimensional culture.
    Burian E; Probst F; Palla B; Riedel C; Saller MM; Cornelsen M; König F; Schieker M; Otto S
    J Craniomaxillofac Surg; 2017 Mar; 45(3):414-419. PubMed ID: 28110999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.